Unknown

Dataset Information

0

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.


ABSTRACT: To examine the feasibility of continuous glucose monitoring (CGM) use in very young children with type 1 diabetes (T1D).Twenty-three children less than 4 yr of age with T1D were provided with a FreeStyle Navigator(®) (n = 21) or a Paradigm(®) (n = 2) CGM device. At baseline, mean age was 3.0 ± 0.8 yr, mean hemoglobin A1c (HbA1c) was 8.0 ± 0.8%, 10 were using an insulin pump and 13 were on multiple daily injections. CGM use was evaluated over a 6-month period.Three children dropped out of the study before the end of 6 months. Among the 20 children who completed 6 months of follow-up, CGM use in month 6 was ?6 d/wk in 9 (45%), 4 ? 6 d/wk in 2 (10%), and <4 d/wk in 9 (45%). Skin reactions were minimal. Although there was no detectable change in mean HbA1c between baseline and 6 months (7.9 and 8.0%, respectively), there was a high degree of parental satisfaction with CGM as measured on the CGM satisfaction scale questionnaire. A high percentage of glucose values were in the hyperglycemic range, and biochemical hypoglycemia was infrequent.More than 40% of very young children were able to safely use CGM on a near-daily basis after 6 months. CGM demonstrated frequent hyperglycemic excursions, with a large variability in glucose readings. Although improvement in glycemic control was not detected in the group as a whole, parental satisfaction with CGM was high.

SUBMITTER: Tsalikian E 

PROVIDER: S-EPMC3665108 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.

Tsalikian Eva E   Fox Larry L   Weinzimer Stuart S   Buckingham Bruce B   White Neil H NH   Beck Roy R   Kollman Craig C   Xing Dongyuan D   Ruedy Katrina K  

Pediatric diabetes 20111213 4


<h4>Objective</h4>To examine the feasibility of continuous glucose monitoring (CGM) use in very young children with type 1 diabetes (T1D).<h4>Research design and methods</h4>Twenty-three children less than 4 yr of age with T1D were provided with a FreeStyle Navigator(®) (n = 21) or a Paradigm(®) (n = 2) CGM device. At baseline, mean age was 3.0 ± 0.8 yr, mean hemoglobin A1c (HbA1c) was 8.0 ± 0.8%, 10 were using an insulin pump and 13 were on multiple daily injections. CGM use was evaluated over  ...[more]

Similar Datasets

| S-EPMC2646024 | biostudies-literature
| S-EPMC3064030 | biostudies-literature
| S-EPMC2875436 | biostudies-literature
| S-EPMC2713649 | biostudies-literature
| S-EPMC5444486 | biostudies-other